GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Asensus Surgical Inc.
Asensus Surgical develops a robotic surgical system. Its stock price is a story of the battle for market share in a market dominated by Intuitive Surgical. The chart reflects the slow adoption of its technology and its dependence on sales news and regulatory approvals.
Share prices of companies in the market segment - Therapeutic medical equipment
Asensus Surgical develops and manufactures Senhance robotic surgical systems, which help surgeons perform minimally invasive procedures. We've classified it as "Therapeutic Medical Equipment." The chart below shows how investors view the future of robotic surgery.
Broad Market Index - GURU.Markets
Asensus Surgical is a medical device company developing robotic surgical systems that use augmented reality and machine learning to improve surgical outcomes. As a component of the GURU.Markets index, it represents the future of surgery. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
ASXC - Daily change in the company's share price Asensus Surgical Inc.
The daily price change of Asensus Surgical, Inc., a developer of surgical robots, reflects volatility in the MedTech sector. The indicator demonstrates sensitivity to sales of its systems and competition in the robotic surgery market.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems for laparoscopy. The robotic surgery market is growing rapidly, but it is highly competitive. The chart below shows the volatility in the medical technology sector, helping to assess how ASXC shares are responding to innovation.
Daily change in the price of a broad market stock, index - GURU.Markets
Asensus Surgical develops robotic surgical systems. The company's shares are a venture bet on a breakthrough in medical robotics. Their high, speculative volatility is part of the dynamics of the innovation sector, influencing the entire market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Asensus Surgical Inc.
For Asensus Surgical, Inc., year-over-year performance is a story of its battle for market share in surgical robotics. Its market capitalization over the past 12 months reflects its success (or failure) in selling its Senhance® system, as well as its strategic shift toward developing new, more innovative technologies to compete with giant Intuitive Surgical.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
As a developer of robotic surgical systems, Asensus is a risky but potentially highly rewarding bet on disrupting a market dominated by Intuitive Surgical. Its performance relative to the sector will reveal how much investors believe in its technology and its ability to compete with the giant.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Asensus Surgical, a company developing robotic surgical systems, aims to make robotic surgery more accessible. Its year-over-year market capitalization reflects how well it competes with giant Intuitive Surgical and how quickly hospitals are adopting its technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Asensus Surgical Inc.
Asensus Surgical is a manufacturer of surgical robots. Its monthly performance reflects progress in commercializing its Senhance system. Quarterly reports on system sales and procedure growth are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems, aiming to make robotic surgery more accessible. This medical technology sector is growing rapidly. The chart below shows how investors assessed the prospects of new players challenging the surgical robot market leaders and their technological innovations.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Asensus Surgical develops robotic surgical systems. It is a high-tech medical device company challenging market leaders. Its stock price is a venture bet that its innovative technology will be adopted by surgeons and hospitals worldwide.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Asensus Surgical Inc.
Shares of Asensus Surgical, a developer of robotic surgical systems, reflect progress in this field. Weekly price movements depend on news about sales of their systems to clinics, regulatory approvals, and competition from giant Intuitive Surgical. The chart below shows how short-term developments in MedTech affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems. This is a market with enormous potential, dominated by a single player. The chart will reveal whether investors believe Asensus can compete and capture a share of the future of robotic surgery.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Asensus Surgical is a medical technology startup. This chart compares its weekly volatility with the market. It shows how its stock, like other early-stage companies, is driven by news about the implementation of its technology rather than by overall market trends.
Market capitalization of the company, segment and market as a whole
ASXC - Market capitalization of the company Asensus Surgical Inc.
The price chart of Asensus Surgical, Inc. reflects its attempt to compete in the robotic surgery market with its Senhance robot. The company's market cap reflects investor skepticism about its ability to challenge Intuitive Surgical's dominance. Its dynamics illustrate this uphill battle for market share.
ASXC - Share of the company's market capitalization Asensus Surgical Inc. within the market segment - Therapeutic medical equipment
Asensus Surgical's market share in the therapeutic equipment sector reflects its commitment to making robotic surgery more accessible. Its market share is based on its Senhance platform, which offers surgeons the benefits of robotics with unique features such as haptic feedback.
Market capitalization of the market segment - Therapeutic medical equipment
The chart below is a barometer of the robotic surgery market. Asensus Surgical is one of the innovators striving to make laparoscopic surgeries more precise. The dynamics in the diagram reflect both the enormous potential and the fierce competition from the dominant market leader.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of robotic surgery. Asensus Surgical's market cap is a bet on its system, which promises to make laparoscopic surgeries more precise and accessible. The line shows how medical equipment innovations are competing for a share of the future of global medicine.
Book value capitalization of the company, segment and market as a whole
ASXC - Book value capitalization of the company Asensus Surgical Inc.
This chart illustrates Asensus Surgical's technological foundation. Its assets include patents and manufactured Senhance® robotic surgical systems. The chart's dynamics demonstrate the company's investment in developing and advancing its platform, which offers digital enhancements for laparoscopic surgery.
ASXC - Share of the company's book capitalization Asensus Surgical Inc. within the market segment - Therapeutic medical equipment
Asensus Surgical's tangible assets include its R&D centers and production lines for robotic surgical systems. The chart shows the company's share of this high-tech medical infrastructure, which aims to make surgery more digital and accessible.
Market segment balance sheet capitalization - Therapeutic medical equipment
In the capital-intensive world of medical equipment, Asensus Surgical operates at the forefront of robotics. Its business requires manufacturing capacity to create its surgical robots, making its model moderately capital-intensive but with a significant intellectual component.
Book value of all companies included in the broad market index - GURU.Markets
Asensus Surgical develops robotic surgical systems that aim to make laparoscopy more precise and accessible. The company's assets include factories producing these sophisticated "surgical assistants." The graph shows the material footprint this company is aiming to occupy in the operating rooms of the future.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Asensus Surgical Inc.
Asensus Surgical develops robotic surgical systems. Its value lies in its technology and patents. The chart below is a bet on the future of surgery. The market valuation reflects investors' belief that its system will be competitive with market giants and will be in demand in hospitals worldwide.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Asensus Surgical, Inc. develops robotic surgical systems. Its value lies in its technology, which aims to make robotic surgery more accessible. This chart shows how its market valuation, reflecting the expected success of its platform, relates to its tangible assets.
Market to book capitalization ratio for the market as a whole
Asensus Surgical develops robotic surgical systems. The company's market valuation, shown in this chart, is based on the potential of its Senhance technology. Investors evaluate its ability to compete with market leaders and implement its systems in hospitals.
Debts of the company, segment and market as a whole
ASXC - Company debts Asensus Surgical Inc.
Asensus Surgical, a company developing robotic surgical systems, is using raised capital to fund its R&D and commercial efforts. This chart shows how the company is attempting to compete with giant Intuitive Surgical by investing in its technology and trying to prove its benefits to surgeons and hospitals.
Market segment debts - Therapeutic medical equipment
Asensus Surgical (formerly TransEnterix) is developing a robotic surgical platform. This chart shows how its high debt load reflects its massive R&D and commercialization expenditures in an attempt to compete with the dominant player in the robotic surgery market, Intuitive Surgical.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Asensus Surgical Inc.
Athene Holding is a large company specializing in pension insurance products, particularly annuities. Its business model is closely tied to managing a massive investment portfolio. This chart provides insight into its complex financial structure and the use of leverage to generate investment income.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems, aiming to make robotic surgery more accessible. This chart compares its debt to the overall market capitalization of the entire sector. It shows how the company finances its capital-intensive developments and competes with giant Intuitive Surgical.
Debt to book value of all companies in the market
Asensus Surgical develops robotic surgical systems. Implementing such complex and expensive systems in hospitals is a lengthy process. This chart of total market debt helps understand the financial environment in which Asensus is raising capital for R&D and marketing to convince surgeons and hospital administrators of the benefits of its technology.
P/E of the company, segment and market as a whole
P/E - Asensus Surgical Inc.
This metric for Asensus Surgical, a developer of robotic surgery systems, shows its valuation against a strong competitor. A P/E ratio (if developed) would reflect investors' belief that its technology can offer advantages and capture market share in a market dominated by Intuitive Surgical.
P/E of the market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems for laparoscopic procedures. Their Senhance platform aims to digitize surgery, providing doctors with improved visualization and ergonomics. This chart shows the average valuation for the therapeutic equipment sector, reflecting how investors view competitors in the growing field of surgical robotics.
P/E of the market as a whole
Asensus Surgical develops and markets the Senhance robotic surgical platform, which uses augmented reality and haptic feedback to improve the precision of laparoscopic surgeries. This risk appetite chart helps understand how investors evaluate innovations in medical robotics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Asensus Surgical Inc.
Asensus Surgical (formerly TransEnterix) is developing the Senhance robotic surgical system, which utilizes augmented reality and haptic feedback. This graph reflects future revenue expectations, which depend on hospital adoption and competition in the robotic surgery market.
%20P%2FE%20Asensus%20Surgical%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Asensus-Surgical-Inc.&v=1772513573522 "Chart of the company's future (projected) P/E Asensus Surgical Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Asensus Surgical is developing the Senhance robotic surgical system, aiming to offer an alternative to the dominant da Vinci system. This chart shows how investors view its chances of success. It compares expectations for Asensus with those of other medical device manufacturers vying for market share.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513573550 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Asensus Surgical develops robotic surgical systems with the goal of making robotic surgery more accessible. The implementation of their Senhance platform depends on hospital budgets. The overall economic climate, illustrated in this graph, influences medical institutions' willingness to invest in new, capital-intensive technologies to improve treatment outcomes.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513573575 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Asensus Surgical Inc.
Asensus Surgical is developing the Senhance robotic surgical platform, which aims to digitize laparoscopic surgery. The company's financial results depend on sales of its systems and instruments to hospitals. This chart shows the company's progress in pursuing a position in the robotic surgery market through innovation and lower costs.
Profit of companies in the market segment - Therapeutic medical equipment
Asensus Surgical is developing the Senhance® robotic surgical platform, which utilizes augmented reality and machine vision. This graph, showing overall sector profitability, reflects the future of surgery. Asensus' success in implementing its more digital and open platform could transform the robotic surgery market and impact the entire industry.
Overall market profit
Asensus Surgical develops robotic surgical systems. The company strives to make robotic surgery more accessible and intelligent. Its success depends on its ability to compete with market leaders and demonstrate the benefits of its platform to hospitals and surgeons.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Asensus Surgical Inc.
Asensus Surgical develops robotic surgical systems. Future profit projections depend on sales and the adoption of its Senhance platform in hospitals worldwide. Analysts are assessing competition in the surgical robot market and the growth in the number of procedures.
%20profit%20of%20the%20company%20Asensus%20Surgical%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Asensus-Surgical-Inc.&v=1772513573653 "Graph of future (projected) profit of the company Asensus Surgical Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems that use machine vision and AI to improve surgical outcomes. This chart shows revenue forecasts for the therapeutic medical equipment sector. It allows you to assess how the company's innovative platform compares to the competition and overall trends in robotics in medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513573675 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Asensus Surgical develops robotic surgical systems. The implementation of such expensive technologies depends on hospital capital budgets. This graph, reflecting the overall economic situation, is important to Asensus. During periods of growth, medical institutions have greater financial capacity to invest in innovative equipment to improve surgical quality.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513573705 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Asensus Surgical Inc.
Asensus Surgical develops robotic surgical systems for laparoscopic procedures. This multiple, which relates market capitalization to revenue from system sales, reflects its attempt to compete with the market leader. It shows how investors view its technology and its ability to convince hospitals to adopt its robotic platform.
P/S market segment - Therapeutic medical equipment
Asensus Surgical is developing the Senhance® robotic surgical platform, which aims to make robotic surgery more accessible and provide surgeons with expanded capabilities. This chart reflects the market's willingness to pay for revenue in the medical technology sector, demonstrating investor confidence in the future of robotic surgery and the Asensus platform.
P/S of the market as a whole
Asensus Surgical, formerly TransEnterix, is developing the Senhance robotic surgical system, which provides surgeons with digital laparoscopy with haptic feedback. This chart shows how the market values companies challenging the leader in surgical robotics.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Asensus Surgical Inc.
Asensus Surgical develops the Senhance robotic surgical platform. This chart shows how investors value the company based on its projected future sales of systems and instruments. It reflects confidence in the growth of the robotic surgery market and the ability of its technology to compete with the market leader.
%20P%2FS%20Asensus%20Surgical%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Asensus-Surgical-Inc.&v=1772513573790 "The graph of the company's future (projected) P/S Asensus Surgical Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Asensus Surgical is developing the Senhance robotic surgical platform, which utilizes augmented reality and machine vision. The chart shows the average future revenue estimates for therapeutic device manufacturers. It helps understand how the market views Asensus's technology and its ability to compete with Intuitive Surgical's dominant da Vinci platform.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513573813 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Asensus Surgical (ASXC) is developing next-generation robotic surgical systems. Their success depends on the implementation of their technology in hospitals and the demonstration of its benefits. This graph is important because economic growth allows clinics to invest in innovation, but the technological race in medicine is a more powerful factor.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513573823 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Asensus Surgical Inc.
This chart shows the revenue of Asensus Surgical, a company that develops robotic surgical systems. Revenue is generated from sales of these systems to hospitals, as well as from instrument sales and maintenance services. The growth of this figure reflects the adoption of its innovative technology in operating rooms worldwide.
Sales of companies in the market segment - Therapeutic medical equipment
Asensus Surgical (formerly TransEnterix) develops robotic surgical systems. Its revenue breakdown shows how much of its revenue comes from sales of the robots themselves, and how much from disposable instruments and service, which are key to long-term profitability in this industry.
Overall market sales
Asensus Surgical, Inc. develops robotic surgical systems. Demand for its expensive equipment depends on hospital capital budgets and their commitment to innovation. This dynamic, reflecting the overall economic health of the healthcare system, influences its financial health and its ability to invest in new technologies to improve patient outcomes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Asensus Surgical Inc.
Asensus Surgical develops robotic surgical systems with the goal of making robotic surgery more accessible. Future sales depend on the implementation of its Senhance system in hospitals. This chart reflects expectations for the surgical robot market.
%20sales%20of%20the%20company%20Asensus%20Surgical%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Asensus-Surgical-Inc.&v=1772513573899 "Schedule of future (projected) sales of the company Asensus Surgical Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Asensus Surgical, formerly TransEnterix, is developing the Senhance robotic surgical platform for laparoscopic procedures. This chart shows the forecast for the therapeutic medical equipment sector. It reflects the growing adoption of robotic surgery, aimed at increasing precision and reducing invasiveness.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513573951 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
This graph, reflecting investments in medical technology, is important for Asensus Surgical. The company develops robotic surgical systems. The implementation of such expensive innovations in clinics depends on their budgets and willingness to invest in modernization, which is possible in a stable economy.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513573961 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Asensus Surgical Inc.
Asensus Surgical is developing a robotic surgical platform that uses augmented reality and machine learning. This chart shows financial results at the commercialization stage. Profitability is determined by system sales to hospitals and recurring revenue from instruments and maintenance.
Market segment marginality - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems that use augmented reality and machine learning to improve surgical precision. Profitability depends on the implementation of its systems in hospitals. This chart shows the average profitability in the sector, helping to assess the competitiveness of Asensus's innovative platform.
Market marginality as a whole
Asensus Surgical develops robotic surgical systems. Demand for such expensive equipment depends on hospitals' capital budgets and their commitment to innovation. This dynamic, reflecting the overall economic health of the country, influences the financial health of healthcare systems, which determines their ability to invest in advanced medical technologies.
Employees in the company, segment and market as a whole
Number of employees in the company Asensus Surgical Inc.
Asensus Surgical, Inc. is developing a robotic surgical platform for laparoscopic procedures. This chart reflects the size of its team of engineers, clinicians, and sales specialists. This dynamic illustrates how the company is competing in the surgical robotics market as it strives to introduce its technology to hospitals worldwide.
Share of the company's employees Asensus Surgical Inc. within the market segment - Therapeutic medical equipment
Asensus Surgical develops the Senhance robotic surgical system, which offers surgeons a digital platform for laparoscopy. This chart shows the company's share of the total number of engineers and clinicians in the robotic surgery niche. This reflects its competition with giant Intuitive Surgical and its unique technological approach.
Number of employees in the market segment - Therapeutic medical equipment
Asensus Surgical, Inc. is developing the Senhance® robotic surgical platform, which expands the capabilities of laparoscopic surgery. This chart, showing employment in the therapeutic medical equipment sector, is important. The growing number of engineers and surgeons using robotics demonstrates technological advances in minimally invasive surgery.
Number of employees in the market as a whole
Asensus Surgical develops robotic surgical systems. The implementation of such expensive technologies depends on the financial health of hospitals. This overall employment chart reflects the economic foundation of the healthcare system. A stable labor market ensures an influx of insurance premiums, which allows medical centers to invest in innovative equipment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Asensus Surgical Inc. (ASXC)
Asensus Surgical (ASXC) is a company developing robotic surgical systems (the Senhance platform). This is the intersection of R&D (intellectual capital) and capital-intensive manufacturing. This metric reflects the high valuation of their robotic surgery technologies and patents per engineer.
%20of%20the%20company%20Asensus%20Surgical%20Inc.%20(ASXC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Asensus-Surgical-Inc.-ASXC&v=1772513574477 "Chart of market capitalization per employee (in thousands of dollars) of the company Asensus Surgical Inc. (ASXC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems. This is a high-tech industry where value is created through innovation, patents, and complex engineering. This chart shows how highly the market values technologies that could change the future of surgery, created by a relatively small team.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513574481 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Asensus Surgical develops robotic surgical systems. It is a high-tech medical device company. Its high employee valuation reflects the company's significant investment in intellectual property, research, and development, where its team of engineers and physicians creates complex systems that could change the future of surgery.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513574513 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Asensus Surgical Inc. (ASXC)
Asensus Surgical (formerly TransEnterix) is developing the Senhance robotic surgical system, which competes with giant Intuitive Surgical. This is an extremely complex and capital-intensive medical technology R&D operation. This chart shows how much the company is spending (negative profit) on each engineer and salesperson in an attempt to penetrate this challenging market.
%20Chart%20Asensus%20Surgical%20Inc.%20(ASXC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Asensus-Surgical-Inc.-ASXC&v=1772513574540 "Company Profit Per Employee (in thousands of dollars) Chart Asensus Surgical Inc. (ASXC)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Asensus Surgical develops robotic surgical systems. This chart demonstrates how effectively the company is commercializing its complex medical technologies. Success in this field requires significant investment in R&D and marketing, and growth in this indicator will indicate growing acceptance and adoption of their systems in hospitals worldwide.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513574558 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Asensus Surgical (ASXC) is a company (formerly TransEnterix) that develops robotic surgical systems (Senhance). It's a MedTech company. This metric is negative because the company incurs enormous R&D costs on personnel (engineers) while trying to compete with giants (Intuitive Surgical) in a capital-intensive industry.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513574584 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Asensus Surgical Inc. (ASXC)
Asensus Surgical develops robotic surgical systems. This chart shows how the company is attempting to compete in a market dominated by Intuitive Surgical. Increasing revenue per employee will indicate successful implementation of their Senhance platform in hospitals worldwide.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Asensus-Surgical-Inc.-ASXC&v=1772513574618 "Sales chart per company employee Asensus Surgical Inc. (ASXC)")
Sales per employee in the market segment - Therapeutic medical equipment
Asensus Surgical (formerly TransEnterix) is developing the Senhance robotic surgical system, a competitor to the da Vinci. They are an R&D and manufacturing company specializing in medical equipment. This chart shows their current stage of commercialization. Their team's productivity lies in their ability to sell and install these expensive robotic systems.
Sales per employee for the market as a whole
Global Ship Lease (GSL) owns and leases (charters) container ships of various sizes to major liner operators (such as Maersk or CMA CGM). This is a pure hardware leasing model. This schedule is classic shipping. GSL is essentially a lessor. They have a small staff managing long-term fleet charter contracts worth billions. This ensures very high returns per employee.
Short shares by company, segment and market as a whole
Shares shorted by company Asensus Surgical Inc. (ASXC)
Asensus Surgical (ASXC), formerly TransEnterix, has been trying to compete in robotic surgery with giant Intuitive Surgical (Da Vinci) for years. This chart shows the volume of short positions. The bears are betting that the company will fail to gain market share and will burn through all its cash.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Asensus-Surgical-Inc.-ASXC&v=1772513574668 "Short Shares Chart for the Company Asensus Surgical Inc. (ASXC)")
Shares shorted by market segment - Therapeutic medical equipment
Asensus Surgical (ASXC) is developing robotic surgical systems (Senhance), aiming to compete with market giants. The chart below shows the overall short position on the robotic surgery sector. It demonstrates how skeptical investors are of the ability of smaller players to break into this capital-intensive market.
Shares shorted by the overall market
Asensus Surgical (ASXC) produces surgical robots. This is an expensive, innovative technology. When this fear indicator rises, investors anticipate a recession. They fear that hospitals, faced with budget cuts, will immediately freeze purchases of expensive, "unproven" equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Asensus Surgical Inc. (ASXC)
This oscillator for Asensus Surgical is a barometer of the battle for the robotic surgery market. The company (formerly TransEnterix) is trying to promote its Senhance system, competing with giant Intuitive Surgical. "Overheating" (above 70) occurs on news of the system's sale to a hospital. Slow adoption and unprofitability lead to "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Asensus-Surgical-Inc.-ASXC&v=1772513574790 "RSI 14 indicator chart for the company's stock Asensus Surgical Inc. (ASXC)")
RSI 14 Market Segment - Therapeutic medical equipment
Asensus is a "robot surgeon" 2.0. They are *not* Intuitive Surgical, but a *competitor* that makes a *robotic* system (Senhance) for *laparoscopy*. The "Therapeutic medical equipment" (medtech/robots) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is ASXC's growth a niche or a general "overheating"?
RSI 14 for the overall market
Asensus Surgical (ASXC), a cash-burning biotech, is on the rise. This chart is its lifeline. During periods of market euphoria, investors are willing to "buy the dream" and fund unprofitable R&D projects. During moments of panic, the cash tap is turned off, and investors demand profits rather than promises, putting ASXC at risk of survival.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ASXC (Asensus Surgical Inc.)
Asensus Surgical is developing the Senhance robotic surgical system, offering surgeons "digital" laparoscopy. This chart shows the analysts' average 12-month forecast. It reflects their view on whether Asensus will be able to compete with the dominant Intuitive Surgical and convince hospitals to purchase their system.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ASXC-Asensus-Surgical-Inc.&v=1772513574973 "A chart showing analyst consensus forecasts for the expected stock price. ASXC (Asensus Surgical Inc.)")
The difference between the consensus estimate and the actual stock price ASXC (Asensus Surgical Inc.)
Asensus Surgical (ASXC) is a "surgical innovator." The company develops a robotic surgical platform (Senhance) that offers surgeons digital vision (haptics). This chart measures the gap between the current price and the consensus target price. It shows whether experts believe they can challenge the dominance of Intuitive Surgical (Da Vinci).
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ASXC-Asensus-Surgical-Inc.&v=1772513575048 "A chart showing the difference between the consensus forecast and the actual stock price. ASXC (Asensus Surgical Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Asensus Surgical (ASXC) is a company attempting to displace Intuitive Surgical. It has developed the Senhance robotic surgical platform, promising "digital" laparoscopy. This chart shows general expectations for the therapeutic medical equipment sector, reflecting whether experts believe the surgical robot market will grow.
Analysts' consensus forecast for the overall market share price
Asensus Surgical (ASXC) is the "David" of the surgical robotics world, challenging the "Goliath" (Intuitive Surgical). Their Senhance platform offers surgeons "digital" laparoscopy. This chart shows the overall risk appetite. It reflects the extent to which investors are willing to finance the capital-intensive battle for market share and their confidence in hospitals' willingness to spend on new equipment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Asensus Surgical Inc.
Asensus is the David versus Goliath (Intuitive Surgical) of the robotic surgery world. Their signature feature (Senhance) is smart laparoscopy (e.g., haptic feedback), which they claim complements, not replaces, the surgeon. This chart is a summary indicator of their battle for survival. It reflects their (meager) razor sales and their desperate struggle to keep the money going.
AKIMA Market Segment Index - Therapeutic medical equipment
Asensus Surgical is a company challenging the giants of robotic surgery. Their Senhance platform offers surgeons digital control over instruments, reducing the invasiveness of procedures. This chart compares their composite index to the sector, showing how far their robotic surgeon outperforms the competition.
The AKIM Index for the overall market
Asensus Surgical, a developer of robotic surgical systems (Senhance) focused on the digitalization of surgeries, is being acquired by KARL STORZ. This chart, which reflects the market average, serves as a backdrop. It helps assess how this company stacked up against overall macroeconomic trends during the acquisition.
